Program
yeast .beta.-d-glucan
Also written as “TR987 0.1% gel + Standard of Care”, “GLYC-101 gel (1.0 %)” and “GLYC-101 Gel (0.1%)”.
Its studies are mostly in Varicose Ulcer · Wounds and Injuries, led by TR Therapeutics.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| TR Therapeutics | 42 open or running | phase 3since Nov 24, 2024 | Apr 7, 2008 | Dec 2026phase 3 · NCT06707103 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 7, 2008First study: phase 2 study in Wounds and InjuriesFirst studyNCT00656474 · 12 enrolled · United States
- Nov 14, 2008Phase 2 study in Wounds and InjuriesNCT00792688 · 26 enrolled · United States
- Nov 24, 20242 phase 3 studies in Varicose UlcerNCT06707103, NCT06707090
Ahead
- Dec 2026Primary completion: phase 3 study in Varicose UlcerNCT06707103
- Dec 2027Primary completion: phase 3 study in Varicose UlcerNCT06707090
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06707103Varicose Ulcer · United States, Australia | 3 | Recruiting | Dec 2026 | 312 |
| NCT06707090Varicose Ulcer · United States | 3 | Recruiting | Dec 2027 | 312 |
| NCT00792688Wounds and Injuries · United States | 2 | Completed | Jan 2010 | 26 |
| NCT00656474Wounds and Injuries · United States | 2 | Completed | Apr 2008 | 12 |
How it is read
Names in the registry
- “TR987 0.1% gel + Standard of Care”, 2 entries
- “GLYC-101 gel (1.0 %)”, 1 entry
- “GLYC-101 Gel (0.1%)”, 1 entry
- “GLYC-101 Gel (1.0%)”, 1 entry
Codes read as this program: TR987.
Conditions, from the studies’ own filings
- Varicose Ulcer, 2 studies
- Wounds and Injuries, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.